The real options approach justifies the launch of a “pilot” project with a negative Net Present Value (NPV) by changing the perspective of the valuation: instead of considering this project as an isolated and loss-making investment, it treats it as the payment of a premium to acquire information and access potentially very profitable future opportunities.

Here are the detailed mechanisms by which this justification operates:

1. The pilot project as a purchase of information (The Premium)

In the classic analysis, a project with a negative NPV destroys value and must be rejected. The optional approach reinterprets this initial loss:

• Cost of information: The negative NPV of the pilot project is considered to be the price to pay (the option premium) to reduce uncertainty and acquire critical information (technical feasibility, competitive credibility, market appetite).
• Option Building: The pilot project is not an option in itself, but a process of building an option. It does not yet confer the right to operate a profitable market, but it serves to test whether that right can be acquired. Without this “entry ticket” (the cost of the pilot), the company is definitively closing the door to a potential market.

2. The transition from NPV to ENPV (Expanded Net Present Value)

The optional approach does not only rely on the static VAN (often negative for a pilot), but calculates the ENPV:

• Formula: ENPV = Classic NPV + Value of Flexibility.
• Mechanism: The value of flexibility corresponds to management’s ability to make future decisions based on the results of the pilot (stop if fail, accelerate if successful). This additional value may be sufficient to compensate for the initial negative NPV and make the overall ENPV positive.

3. The logic of “Program” vs. “Project”

Finally, the optional approach invites us not to judge the pilot in isolation, but to integrate him into a sequential vision:

• An individual project may have a negative NPV, but be essential to trigger a program of subsequent investments that are very profitable. The initial loss is accepted because it is the sine qua non  condition for accessing a portfolio of strategic opportunities (new markets, disruptive technologies).
• This is typically the case in the pharmaceutical industry (we invest at a loss in fundamental research (the pilot) to give ourselves the right, later, to launch a “blockbuster”) or technological (we accept a project that we know a priori will not be profitable to demonstrate its ability to meet the needs of the market, but with the ambition of “catching up” on subsequent projects).